阵发性夜间血红蛋白尿患者停用依库珠单抗后可能存在血栓形成事件的高风险。 - Suppr

Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab.

作者信息

van Bijnen Sandra T A, van Rijn Roos S, Koljenovic Senada, te Boekhorst Peter, de Witte Theo, Muus Petra

出版信息

Br J Haematol. 2012 Jun;157(6):762-3. doi: 10.1111/j.1365-2141.2012.09073.x. Epub 2012 Feb 29.

DOI:10.1111/j.1365-2141.2012.09073.x

PMID:22372429

Abstract

摘要

相似文献

Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab.

Br J Haematol. 2012 Jun;157(6):762-3. doi: 10.1111/j.1365-2141.2012.09073.x. Epub 2012 Feb 29.

[Generalized thrombotic diathesis in paroxysmal nocturnal hemoglobinuria (Struebing-Marchiafava-Micheli)].

Med Welt. 1980 Oct 10;31(41):1465-9.

Purpura fulminans in paroxysmal nocturnal haemoglobinuria.

Br J Haematol. 2007 May;137(4):271. doi: 10.1111/j.1365-2141.2007.06522.x.

Learnings from over 25 years of PNH experience: the era of targeted complement inhibition.

Blood Rev. 2013 Dec;27 Suppl 1:S1-6. doi: 10.1016/S0268-960X(13)00080-5.

Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria.

Am J Hematol. 2009 Oct;84(10):699-701. doi: 10.1002/ajh.21506.

[With paroxysmal nocturnal haemoglobinuria and treatment with eculizumab].

Enferm Infecc Microbiol Clin. 2012 Feb;30(2):109-10. doi: 10.1016/j.eimc.2011.10.013. Epub 2011 Dec 22.

Perisurgical induction of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria: its inhibition of surgery-triggered hemolysis and the consequence of subsequent discontinuation.

Blood Coagul Fibrinolysis. 2013 Sep;24(6):658-62. doi: 10.1097/MBC.0b013e328360d057.

Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab.

Leuk Res. 2009 Jun;33(6):e4-5. doi: 10.1016/j.leukres.2008.09.008. Epub 2008 Oct 25.

Durable resolution of recurrent microvascular small bowel ischaemia and severe abdominal pain by eculizumab in paroxysmal nocturnal haemoglobinuria.

Intern Med J. 2010 Nov;40(11):794-5. doi: 10.1111/j.1445-5994.2010.02315.x.

Rapidly evolving skin manifestations due to progressive thrombosis in a patient with paroxysmal nocturnal haemoglobinuria resolved with prompt initiation of eculizumab.

Br J Dermatol. 2014 Oct;171(4):908-10. doi: 10.1111/bjd.13033. Epub 2014 Oct 8.

引用本文的文献

Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Hepatol Int. 2021 Jun;15(3):531-567. doi: 10.1007/s12072-021-10189-4. Epub 2021 Jul 8.

Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.

Br J Haematol. 2013 Jul;162(1):62-73. doi: 10.1111/bjh.12347. Epub 2013 Apr 25.

Successful anticoagulant therapy for two pregnant PNH patients, and prospects for the eculizumab era.

Int J Hematol. 2013 Apr;97(4):491-7. doi: 10.1007/s12185-013-1302-3. Epub 2013 Mar 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab.

作者信息

出版信息